Aortic Stenosis Journey: Where do we stand and where is the future taking us?

Date: Saturday 26 August
Time: 10:15-11:00 (CEST)
Venue: Hub Van Gogh

Join us and hear more from experts on:

  • The societal, individual, and biological burden of AS undertreatment
  • The time window for effective TAVI treatment depending on patient profiles.
  • The current ESC/EACTS Guidelines: where are the grey zones?


Welcome words
Prof. Tanja Rudolph

Which aortic stenosis patients are we not optimally treating?
Prof. Jan-Malte Sinning

From progressive aortic valve disease to intervention
Prof. Helene Eltchaninoff

To treat or not to treat? Echo challenges
Dr. Martin Swaans

Discussion and audience interaction

Closing words
Prof. Tanja Rudolph


Prof. Tanja Rudolph
Prof. Jan-Malte Sinning
Prof. Helene Eltchaninoff
Dr. Martin Swaans

Join us onsite if you are attending the congress in-person. You can also sign up to receive a symposium recording and post-congress highlights.

Sign up now to receive copies of Edwards Lifesciences recorded event sessions post event, as well as receive event and news informations from Edwards Lifesciences, including:


Featuring the latest cardiology news, clinical trials and real-world evidence in aortic stenosis (AS) management.

Panel discussions

Involving leading cardiologists debating the latest topics in transcatheter aortic valve implantation (TAVI) and AS management.

Conference headlines

Providing insights into the major developments from the latest cardiology events.

Guidelines updates

Highlighting the areas of change within any updated aortic stenosis treatment guidelines.

Medical device for professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult where applicable).

PP--EU-6555 v1.0